Use of cycloalkano[1,2-b]indolesulphonamides in combination with plasminogen activators as drugs in thrombolytic therapy

摘要

The invention relates to the use of cycloalkano[1,2-b]indolesulphonamides in combination with plasminogen activators such as streptokinase, urokinase or tPA. The combination can be used as drug for the treatment of thromboembolic disorders.